Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs - Zacks.com

Submitted by Anonymous (not verified) on Fri, 03/08/2019 - 08:00

Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs  Zacks.comJ&J's (JNJ) Spravato (esketamine) gets approval for treatment-resistant depression. CHMP recommends approval of several drugs.